Suppr超能文献

产科麻醉与围产医学学会关于血小板减少症产科患者神经轴阻滞操作的跨学科共识声明。

The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia.

作者信息

Bauer Melissa E, Arendt Katherine, Beilin Yaakov, Gernsheimer Terry, Perez Botero Juliana, James Andra H, Yaghmour Edward, Toledano Roulhac D, Turrentine Mark, Houle Timothy, MacEachern Mark, Madden Hannah, Rajasekhar Anita, Segal Scott, Wu Christopher, Cooper Jason P, Landau Ruth, Leffert Lisa

机构信息

From the Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan.

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

出版信息

Anesth Analg. 2021 Jun 1;132(6):1531-1544. doi: 10.1213/ANE.0000000000005355.

Abstract

Because up to 12% of obstetric patients meet criteria for the diagnosis of thrombocytopenia in pregnancy, it is not infrequent that the anesthesiologist must decide whether to proceed with a neuraxial procedure in an affected patient. Given the potential morbidity associated with general anesthesia for cesarean delivery, thoughtful consideration of which patients with thrombocytopenia are likely to have an increased risk of spinal epidural hematoma with neuraxial procedures, and when these risks outweigh the relative benefits is important to consider and to inform shared decision making with patients. Because there are substantial risks associated with withholding a neuraxial analgesic/anesthetic procedure in obstetric patients, every effort should be made to perform a bleeding history assessment and determine the thrombocytopenia etiology before admission for delivery. Whereas multiple other professional societies (obstetric, interventional pain, and hematologic) have published guidelines addressing platelet thresholds for safe neuraxial procedures, the US anesthesia professional societies have been silent on this topic. Despite a paucity of high-quality data, there are now meta-analyses that provide better estimations of risks. An interdisciplinary taskforce was convened to unite the relevant professional societies, synthesize the data, and provide a practical decision algorithm to help inform risk-benefit discussions and shared decision making with patients. Through a systematic review and modified Delphi process, the taskforce concluded that the best available evidence indicates the risk of spinal epidural hematoma associated with a platelet count ≥70,000 × 106/L is likely to be very low in obstetric patients with thrombocytopenia secondary to gestational thrombocytopenia, immune thrombocytopenia (ITP), and hypertensive disorders of pregnancy in the absence of other risk factors. Ultimately, the decision of whether to proceed with a neuraxial procedure in an obstetric patient with thrombocytopenia occurs within a clinical context. Potentially relevant factors include, but are not limited to, patient comorbidities, obstetric risk factors, airway examination, available airway equipment, risk of general anesthesia, and patient preference.

摘要

由于高达12%的产科患者符合妊娠期血小板减少症的诊断标准,麻醉医生经常需要决定是否对受影响的患者进行神经轴阻滞操作。考虑到剖宫产全身麻醉存在潜在的并发症,认真思考哪些血小板减少症患者在进行神经轴阻滞操作时发生脊髓硬膜外血肿的风险可能增加,以及这些风险何时超过相对益处,对于考虑并告知患者共同决策非常重要。由于在产科患者中不进行神经轴阻滞镇痛/麻醉操作存在重大风险,应尽一切努力在入院分娩前进行出血史评估并确定血小板减少症的病因。尽管其他多个专业学会(产科、介入疼痛和血液学)已发布关于安全神经轴阻滞操作的血小板阈值指南,但美国麻醉专业学会在这个问题上一直保持沉默。尽管高质量数据匮乏,但现在有荟萃分析能更好地估计风险。为此召集了一个跨学科特别工作组,联合相关专业学会,综合数据,并提供一个实用的决策算法,以帮助进行风险效益讨论并与患者共同决策。通过系统回顾和改进的德尔菲法,特别工作组得出结论,现有最佳证据表明,对于继发于妊娠期血小板减少症、免疫性血小板减少症(ITP)和妊娠期高血压疾病且无其他危险因素的产科血小板减少症患者,血小板计数≥70,000×10⁶/L时发生脊髓硬膜外血肿的风险可能非常低。最终,对于患有血小板减少症的产科患者是否进行神经轴阻滞操作的决定是在临床背景下做出的。潜在的相关因素包括但不限于患者的合并症、产科危险因素、气道检查、可用的气道设备、全身麻醉的风险以及患者的偏好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验